BOT Ann: FDA Qualified Infectious Disease Product Status for BTX 1801 - 28th Apr 2022, 8:40am

annb0t

annb0t

Top 20
BOT Ann: FDA Qualified Infectious Disease Product Status for BTX 1801
Price Sensitive: Y
Date: 28th Apr 2022, 8:40am

>>> Read announcement: Google: BOT Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
BOT Ann: FDA Approves SOFDRA as Trade Name for Sofpironium Bromide - 17th Oct 2023, 9:45am
Replies
0
Views
107
annb0t
annb0t
annb0t
BOT Ann: Presentation- FDA Letter Requires Patient Instruction Update - 26th Sep 2023, 9:23am
Replies
0
Views
66
annb0t
annb0t
annb0t
BOT Ann: FDA Letter Requires Patient Instruction Update - 26th Sep 2023, 9:18am
Replies
0
Views
65
annb0t
annb0t
annb0t
BOT Ann: FDA Mid-Cycle Review Meeting Successfully Completed - 3rd Apr 2023, 8:40am
Replies
0
Views
109
annb0t
annb0t
annb0t
BOT Ann: BOT Submits FDA New Drug Application for Sofpironium Bromide - 26th Sep 2022, 8:19am
Replies
0
Views
211
annb0t
annb0t
Top Bottom